BOONE, NC – Pneuma Respiratory, a startup in Boone focused on inhaler technology, has named a new chairman of its board.
Board member Jay Morgan, former chief operating officer for Merck Consumer Health globally, is the new chairman after Pneuma’s previous chairman Walt Robb stepped down.
Robb remains on the board.
“Jay’s contributions as a member of our Board have been invaluable, and I look forward to working with him in his role as Chairman,” Pneuma chief executive officer and co-founder Eric Hunter said in a statement.
Hunter launched the company in 2015 and is one of Durham-based Cree’s founders.
Pneuma’s lead product is a patented, breath-activated digital inhaler called Pneumahaler. The company markets it as the first of its kind.
The company is also developing digital droplet ejector technology. At present, it’s only available for “investigational purposes,” But Pneuma attests it can deliver a spectrum of novel therapies, including biologics, to the lungs.
Digital inhaler startup led by Cree cofounder Eric Hunter lands $8.3M in funding
